MK Electron Co., Ltd. (KOSDAQ:033160)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,350.00
+150.00 (1.83%)
Last updated: Aug 8, 2025
1.83%
Market Cap171.83B
Revenue (ttm)1.18T
Net Income (ttm)-21.20B
Shares Out20.90M
EPS (ttm)-1,004.37
PE Ration/a
Forward PEn/a
Dividend100.00 (1.22%)
Ex-Dividend DateDec 27, 2024
Volume102,703
Average Volume92,380
Open8,170.00
Previous Close8,200.00
Day's Range8,170.00 - 8,440.00
52-Week Range5,340.00 - 11,000.00
Beta0.73
RSI57.04
Earnings DateAug 14, 2025

About Verve Therapeutics

MK Electron Co., Ltd. develops, manufactures, and markets semiconductor materials in Korea, Taiwan, China, and Southeast Asia. It offers bonding wires and solders balls, including gold bonding wires, copper bonding wires, AG based wires, and advanced Au-Ag-alloy bonding wires, as well as sputtering target products made of gold based alloy, and evaporation materials. The company provides CCSB, solder paste, and solder bar. MK Electron Co., Ltd. was founded in 1982 and is based in Yongin-si, South Korea. [Read more]

Industry Drawing and Insulating of Nonferrous Wire
Founded 1982
Employees 285
Stock Exchange KOSDAQ
Ticker Symbol 033160
Full Company Profile

Financial Performance

In 2024, MK Electron's revenue was 1.17 trillion, an increase of 4.80% compared to the previous year's 1.12 trillion. Losses were -27.04 billion, -23.27% less than in 2023.

Financial Statements

News

There is no news available yet.